107 related articles for article (PubMed ID: 12443768)
1. Vacuolar-type H(+)-ATPase inhibitory activity of synthetic analogues of the concanamycins: is the hydrogen bond network involving the lactone carbonyl, the hemiacetal hydroxy group, and the C-19 hydroxy group essential for the biological activity of the concanamycins?
Yoshimoto Y; Jyojima T; Arita T; Ueda M; Imoto M; Matsumura S; Toshima K
Bioorg Med Chem Lett; 2002 Dec; 12(24):3525-8. PubMed ID: 12443768
[TBL] [Abstract][Full Text] [Related]
2. Induction of EGF-dependent apoptosis by vacuolar-type H(+)-ATPase inhibitors in A431 cells overexpressing the EGF receptor.
Yoshimoto Y; Imoto M
Exp Cell Res; 2002 Sep; 279(1):118-27. PubMed ID: 12213220
[TBL] [Abstract][Full Text] [Related]
3. Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases.
Dröse S; Altendorf K
J Exp Biol; 1997 Jan; 200(Pt 1):1-8. PubMed ID: 9023991
[TBL] [Abstract][Full Text] [Related]
4. Chemistry and structure activity relationships of bafilomycin A1, a potent and selective inhibitor of the vacuolar H+-ATPase.
Gagliardi S; Rees M; Farina C
Curr Med Chem; 1999 Dec; 6(12):1197-212. PubMed ID: 10519916
[TBL] [Abstract][Full Text] [Related]
5. Callyspongiolide Is a Potent Inhibitor of the Vacuolar ATPase.
Fogarty S; Ouyang Y; Li L; Chen YC; Rane H; Manoni F; Parra KJ; Rutter J; Harran PG
J Nat Prod; 2020 Nov; 83(11):3381-3386. PubMed ID: 33151675
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide production by the vacuolar-type (H+)-ATPase inhibitors bafilomycin A1 and concanamycin A and its possible role in apoptosis in RAW 264.7 cells.
Hong J; Nakano Y; Yokomakura A; Ishihara K; Kim S; Kang YS; Ohuchi K
J Pharmacol Exp Ther; 2006 Nov; 319(2):672-81. PubMed ID: 16895977
[TBL] [Abstract][Full Text] [Related]
7. Iejimalides show anti-osteoclast activity via V-ATPase inhibition.
Kazami S; Muroi M; Kawatani M; Kubota T; Usui T; Kobayashi J; Osada H
Biosci Biotechnol Biochem; 2006 Jun; 70(6):1364-70. PubMed ID: 16794315
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of modified bafilomycins and concanamycins on P- and V-type adenosinetriphosphatases.
Dröse S; Bindseil KU; Bowman EJ; Siebers A; Zeeck A; Altendorf K
Biochemistry; 1993 Apr; 32(15):3902-6. PubMed ID: 8385991
[TBL] [Abstract][Full Text] [Related]
9. Increase in Bcl-2 level promoted by CD40 ligation correlates with inhibition of B cell apoptosis induced by vacuolar type H(+)-ATPase inhibitor.
Akifusa S; Ohguchi M; Koseki T; Nara K; Semba I; Yamato K; Okahashi N; Merino R; Núñez G; Hanada N; Takehara T; Nishihara T
Exp Cell Res; 1998 Jan; 238(1):82-9. PubMed ID: 9457059
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of fluorinated analogues of salicylihalamide.
Sugimoto Y; Konoki K; Murata M; Matsushita M; Kanazawa H; Oishi T
J Med Chem; 2009 Feb; 52(3):798-806. PubMed ID: 19117395
[TBL] [Abstract][Full Text] [Related]
11. Semisynthetic derivatives of concanamycin A and C, as inhibitors of V- and P-type ATPases: structure-activity investigations and developments of photoaffinity probes.
Dröse S; Boddien C; Gassel M; Ingenhorst G; Zeeck A; Altendorf K
Biochemistry; 2001 Mar; 40(9):2816-25. PubMed ID: 11258892
[TBL] [Abstract][Full Text] [Related]
12. Concanamycin A, the specific inhibitor of V-ATPases, binds to the V(o) subunit c.
Huss M; Ingenhorst G; König S; Gassel M; Dröse S; Zeeck A; Altendorf K; Wieczorek H
J Biol Chem; 2002 Oct; 277(43):40544-8. PubMed ID: 12186879
[TBL] [Abstract][Full Text] [Related]
13. Specific inhibitors of vacuolar type H(+)-ATPases induce apoptotic cell death.
Nishihara T; Akifusa S; Koseki T; Kato S; Muro M; Hanada N
Biochem Biophys Res Commun; 1995 Jul; 212(1):255-62. PubMed ID: 7612014
[TBL] [Abstract][Full Text] [Related]
14. Increased production of reactive oxygen species by the vacuolar-type (H(+))-ATPase inhibitors bafilomycin A1 and concanamycin A in RAW 264 cells.
Yokomakura A; Hong J; Ohuchi K; Oh SE; Lee JY; Mano N; Takahashi T; Hwang GW; Naganuma A
J Toxicol Sci; 2012; 37(5):1045-8. PubMed ID: 23038011
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and V-ATPase inhibition of simplified lobatamide analogues.
Shen R; Lin CT; Bowman EJ; Bowman BJ; Porco JA
Org Lett; 2002 Sep; 4(18):3103-6. PubMed ID: 12201727
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of vacuolar-type H(+)-ATPase suppresses proliferation of cultured cells.
Manabe T; Yoshimori T; Henomatsu N; Tashiro Y
J Cell Physiol; 1993 Dec; 157(3):445-52. PubMed ID: 8253855
[TBL] [Abstract][Full Text] [Related]
17. Activation of melanogenesis by vacuolar type H(+)-ATPase inhibitors in amelanotic, tyrosinase positive human and mouse melanoma cells.
Ancans J; Thody AJ
FEBS Lett; 2000 Jul; 478(1-2):57-60. PubMed ID: 10922469
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationships of bafilomycin A1 derivatives as inhibitors of vacuolar H+-ATPase.
Gagliardi S; Gatti PA; Belfiore P; Zocchetti A; Clarke GD; Farina C
J Med Chem; 1998 May; 41(11):1883-93. PubMed ID: 9599238
[TBL] [Abstract][Full Text] [Related]
19. V-ATPases as drug targets.
Bowman EJ; Bowman BJ
J Bioenerg Biomembr; 2005 Dec; 37(6):431-5. PubMed ID: 16691478
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the gene encoding the V-ATPase subunit A results in inhibition of normal growth and abolished sporulation in Aspergillus nidulans.
Melin P; Schnürer J; Wagner EGH
Microbiology (Reading); 2004 Mar; 150(Pt 3):743-748. PubMed ID: 14993324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
